BioNTech CEO Says Vaccine Likely to Protect Against Severe COVID From Omicron

FRANKFURT — BioNTech and Pfizer’s COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech’s Chief Executive told Reuters, as the firm weighs the need to upgrade its commonly used shot. Read More